| Topic | Date | Title | Slides and Agendas |
|---|---|---|---|
| Novel Anticoagulants | February 3, 2015 | NOAC Reversal Agent Think Tank Follow-up: Post-Approval Safety and Effectiveness | Slides & Agenda |
| Annual Meeting | February 19, 2015 | 2015 Annual Meeting | Slides & Agenda |
| Sudden Cardiac Death | February 20, 2015 | Prevention of Sudden Cardiac Death in the Young: Developing A Rational, Reliable and Sustainable National Health Care Resource | Slides & Agenda |
| Cell Therapies for CV Indications | October 23, 2015 | CSRC Roundtable Discussion: Cardiovascular Safety for Cell Therapies in Development for Cardiovascular Indications | Slides & Agenda |
| Social Listening | November 4, 2015 | CSRC/DIA: Social Listening and Safety Surveillance— Enabling Opportunities for Cardiac Safety | Slides |
| Long-Term Electrocardiographic Monitoring | December 2, 2015 | Long Term Electrocardiographic Monitoring: Its Role in Clinical Drug Development and Population Screening | Slides & Agenda |
| Novel Anticoagulants | December 3, 2015 | Is There a Role For Pharmacokinetic/Pharmacodynamics Guided Dosing For Novel Anticoagulants? | Slides & Agenda |